title: Changes in hormones, lipids and symptoms after the administration of a commercial preparation with dehydroepiandrosterone in postmenopausal women.
authors.affiliation: Gynecologic Endocrinology Service, Hospital de Ginecología y Obstetricia Luis Castelazo Ayala. scarranzal@mexis.com
authors.forename: S
authors.initials: S
authors.lastname: Carranza-Lira
authors.forename: J L
authors.initials: JL
authors.lastname: Nájera Mojica
authors.forename: J
authors.initials: J
authors.lastname: Herrera
authors.forename: D
authors.initials: D
authors.lastname: Ramos-Ponce
authors.forename: A
authors.initials: A
authors.lastname: Olivares-Segura
authors.forename: G
authors.initials: G
authors.lastname: Cardoso-Saldaña
authors.forename: C
authors.initials: C
authors.lastname: Posadas-Romero
mesh_terms: D000368:Aged; D015992:Body Mass Index; D002784:Cholesterol / Q000097:blood; D003687:Dehydroepiandrosterone / Q000097:blood / Q000494:pharmacology*; D005260:Female; D006728:Hormones / Q000097:blood*; D006801:Humans; D008055:Lipids / Q000097:blood*; D008875:Middle Aged; D017698:Postmenopause / Q000502:physiology*; D014280:Triglycerides / Q000097:blood
chemical_list: D006728:Hormones; D008055:Lipids; D014280:Triglycerides; D003687:Dehydroepiandrosterone; D002784:Cholesterol